Results of the Destination Therapy Post-Food and Drug Administration Approval Study With a Continuous Flow Left Ventricular Assist Device-Reference-Cited by-同舟云学术

Results of the Destination Therapy Post-Food and Drug Administration Approval Study With a Continuous Flow Left Ventricular Assist Device

Published:2014-05 Issue:17 Volume:63 Page:1751-1757
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Jorde Ulrich P.,Kushwaha Sudhir S.,Tatooles Antone J.,Naka Yoshifumi,Bhat Geetha,Long James W.,Horstmanshof Douglas A.,Kormos Robert L.,Teuteberg Jeffrey J.,Slaughter Mark S.,Birks Emma J.,Farrar David J.,Park Soon J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients;Kirklin;J Heart Lung Transplant,2013

2. Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation

3. Advanced heart failure treated with continuous-flow left ventricular assist device;Slaughter;N Engl J Med,2009

4. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients;Rogers;J Am Coll Cardiol,2010

5. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy;Park;Circ Heart Fail,2012

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Long-Term Survival of LVAD Patients—A TriNetX Database Analysis;Journal of Clinical Medicine;2024-07-13

2. Pressure‐dimension index and left ventricular sphericity index following HeartMate II and HeartMate 3 implantation;ESC Heart Failure;2024-06-05

3. Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024);Eurasian heart journal;2024-05-27

4. Advanced Heart Failure: Therapeutic Options and Challenges in the Evolving Field of Left Ventricular Assist Devices;Journal of Cardiovascular Development and Disease;2024-02-16

5. Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC);European Journal of Heart Failure;2024-01-25